The problem extends to the followup, namely loss to followup and related biases in the case of the GP who enrolled the patient into the study was not helpful, or worse...
Sharing widely is not likely to get an article retracted and is likely to be counter-productive. Sharing with prominent people in authority who may be able to leverage a correction on the other hand can be helpful...
This study could be quite valuable if done correctly, but won't be because the people running the study don't bother to listen to patients when it comes to study design...
I think you missed my point. Yes they have a policy. I'm saying that policy does not meet patient needs in all cases. I'm saying we shouldn't be trapped in bureaucratic hell because they didn't bother to ask us before making a policy.
We don't have a name like SEID [Ramsay], we have an even...
Yet another narrative review recommending SSRIs, this one notably does not mention any references. The reason for the lack of references is because all double blinded studies of SSRIs for CFS patients failed to show any benefit for any symptoms including depressive or anxiety symptoms.
I don't...
I think my previous response was badly worded, I mean we don't have serious winter here, like you have in many parts of the USA. (I hear there were even snow storms in California!)
I live in South Australia, it never snows where I live.
Since Jonathan didn't have a go, I will try.
Phantom limb phenomena relates to the fact that the mind (as a result of development of a young organism) builds up a model of the limb and this is used as a comparative basis for proprioception (including effort perception) in general. This is one...
The argument against naming diseases after people is based on stigma, whether the name leads to confusion about etiology etc. Those arguments don't necessarily apply to the argument that ME should be renamed as Ramsay disease.
Secondly, if the names proposed by various health authorities...
This doesn't prove that the conditions are similar, it proves that the questionnaire lacks specificity. Which is something that patients frequently mention when filling out such questionnaires (and often ignored by researchers).
Brenu et al note no difference in deformability using a different methodology.
Saha et al note that some patients were taking various medications such as LDN, Rituxan, Vitamin D etc and this could well affect the results, especially given the small sample size. Secondly, no sensitivity of...
Both the Mirtazapine + CCBT and CCBT + Mirtazapine groups, as well as the Placebo + CCBT and CCBT + Placebo should have similar results at 24 weeks unless the study suffers from short term biases.
The reductions in the Fatigue Scale (Chalder) score at 12 weeks were small and not of clinical...
The study isn't bad, but there is a potential red flag, namely these authors are fishing in the data retrospectively for associations... Now if the authors preregistered their hypotheses and mentioned which hypotheses were tested and found to have null results, their results could be interpreted...
Simon Wessely's "biomedical" research was really designed and conducted by colleagues/grad students, such as Anthony Cleare who did do some novel neuroendocrinology work, but unfortunately didn't find anything particularly interesting.
I have discussed the directionality of symptoms before, namely cognitive effort leads to cognitive PEM, whereas a sufficient amount of physical exercise leads to both physical "crash" and cognitive "crash".
The sensory issues only come when everything is really severe - only when the brain is...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.